Molgramostim

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

GM-CSF

Definition
This section has been translated automatically.

Cytokine, granulocyte-macrophage colony stimulating factor.

Pharmacodynamics (Effect)
This section has been translated automatically.

Proliferation and differentiation of progenitor cells of granulopoiesis, monocytes and macrophages, eosinophils, erythropoiesis and megakaryopoiesis Increase of the production rate of neutrophils by 50%, extension of the circulation half-life of neutrophils from 4 to 48 hours.

Indication
This section has been translated automatically.

Severe neutropenia in patients treated with myelotoxic chemotherapeutic agents.

Dosage and method of use
This section has been translated automatically.

5-10 μg/kg bw/day s.c.

Notice!

Therapy only under supervision of oncologically experienced doctors!

Undesirable effects
This section has been translated automatically.

Fever, nausea, vomiting, diarrhea, dyspnea, rigor, allergic reactions, fatigue, anorexia, bone pain, asthenia, non-specific thoracic pain, stomatitis, headache, sweating, pruritus, dizziness, peripheral edema, paraesthesia, myalgias.

Interactions
This section has been translated automatically.

Decrease of the serum albumin level, possibly dose adjustment of drugs with high binding affinity to serum albumin.

Contraindication
This section has been translated automatically.

Pregnancy, lactation, basic malignant myeloid disease (myelodysplastic syndrome, AML).

Preparations
This section has been translated automatically.

Leucomax (available through the international pharmacy).

Outgoing links (1)

Cytokines;

Authors

Last updated on: 29.10.2020